EDTCO Organ Donation Meeting

SUNDAY 13 SEPTEMBER
09:00 – 16:00 EDTCO Organ Donation Meeting

Session 1: Donation at the end of life: what do we do well and what could we do better?

CHAIRS: Julien Charpentier, Paris, France
              Carl-Ludwig Fischer-Fröhlich, Stuttgart, Germany

09:00     Lessons learned from ACCORD
             Beatriz Domínguez-Gil, Madrid, Spain
             Paul Murphy, Leeds, United Kingdom

09:20     Engaging intensive care professionals in deceased donation: What can the transplant community do?
             Axel Rahmel, DSO, Germany

09:35     What can professional societies do?
             Jacques Duranteau, Paris, France -European Society of Intensive Care Medicine

09:50     What can individuals do?
             Stephan Eschertzhuber, Innsbruck, Austria

10:05 – 10:25      Audience and speakers discussion

10:25 – 10:40      Coffee Break

Session 2: Family approach: theory into practice

CHAIRS: Beatriz Domínguez-Gil, Madrid, Spain
              Dagmar Vernet, Bern, Switzerland

Family approach: the way I do it when…

10:40     Brain death criteria are met
             Paolo Maia, Porto, Portugal

10:55     Brain death is expected, but has not occurred yet
             Teresa Pont, Barcelona, Spain

11:10     Circulatory death is expected to occur following the Withdrawal of Life Sustaining Treatment (Controlled DCD)
             Tineke Wind, Maastricht, The Netherlands

11:25     Unexpected circulatory death occurs following unsuccessful cardiopulmonary resuscitation (Uncontrolled DCD)
             Anna Faucher, Metz, France

11:40 - 12:00       Audience and speakers discussion

12:00 – 13:00      Lunch Break

Session 3: The Moral Maze: Upholding the overall best interests of the dying patient

CHAIRS: Bernadette Haase, Leiden, The Netherlands
              Dirk Ysebaert, Antwerp, Belgium

13:00     Is it ethically and legally defensible to overrule the expressed consent of the dying patient to be an organ donor?
             For: Michael Bos, The Hague, The Netherlands
             Against: David Shaw, Glasgow, United Kingdon

13:20-13:35         Audience and speakers discussion

13:35     Is ethically and legally defensible to initiate and continue active treatment beyond futility to incorporate the option of organ donation in the end-of-life care pathway?
             For:  Dale Gardiner, Nottingham, United Kingdom
             Against: Julien Charpentier, Paris, France

13:55 - 14:10       Audience and speakers discussion

14:10 – 14:25      Coffee Break

Session 4: How can we raise awareness and engage society and the public in the deceased organ donation debate?

CHAIRS: Lisa Burnapp, London, United Kingdom
              David Paredes, Barcelona, Spain

14:25     Advertising for donation after death: what makes a difference?
             Jeantine Reiger,  NTS, The Netherlands

Social media: do the benefits outweigh the risks in engaging the public?           

14:50     Patient perspective
             Nicholas Palmer, Head of Advocacy at the National Kidney Federation

15:00     Donor family perspective
             Tim Overdiek, Amsterdam, The Netherlands

15:10     Healthcare professional perspective
             Carl-Ludwig Fischer-Fröhlich, Stuttgart, Germany

15:20     Journalist perspective
             Melissa Thermidor, Community and Content Manager, NHS Blood and Transplant, United Kingdom

15:30 – 16:00      Audience and panel discussion

_________________________________________________________________________________________________________________________

EDTCO in pills:
EDTCO is a section within ESOT dedicated to donation and procurement activities

Goals:
​- Increase organ and tissue availability
- Ensure the quality and safety of organs and tissues for transplantation
- Optimise the safety of living donors and care for deceased donors and their relatives
- Optimise potential recipient care and follow-up through effective clinical coordination

Aim:
To establish clinically effective programmes in organ and tissue donation, procurement and transplantation by supporting and representing all healthcare professionals involved in the process.

Objectives:
- To promote better understanding of the barriers to deceased donation
- To develop knowledge and skills in end of life care, donor management and family support
- To enhance collaboration between healthcare professionals working in the fields of intensive care medicine and organ and tissue donation

Target audience:
Healthcare professionals involved in intensive care and emergency medicine, end of life care, organ and tissue donation and coordination.
Patient, family and society representatives, EU commissioners and political representatives